Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs

Journal of Liposome Research
Gina SongWilliam C Zamboni

Abstract

Various attempts to increase the therapeutic index of the drug while minimizing side effects have been made in drug delivery systems. Among several promising strategies, liposomes represent an advanced technology to target active molecules to the site of action. Rapid clearance of circulating liposomal drugs administered intravenously has been a critical issue because circulation time in the blood affects drug exposure at the target site. The clinical use of liposomal drugs is complicated by large intra- and interindividual variability in their pharmacokinetics (PK) and pharmacodynamics (PD). Thus, it is important to understand the factors affecting the PK/PD of the liposomal formulation of drugs and to elucidate the mechanisms underlying the variability in the PK/PD of liposomal drugs. In this review article, we describe the characteristics of liposome formulations and discuss the effects of various factors, including liposome-associated factors, host-associated factors, and treatment on the PK/PD of liposomal agents.

References

Aug 14, 1992·Biochimica Et Biophysica Acta·M C Woodle, D D Lasic
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D PapahadjopoulosC Redemann
Sep 30, 1991·Biochimica Et Biophysica Acta·T M Allen, C Hansen
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A S JanoffM W Tate
Nov 1, 1974·Archivum Histologicum Japonicum = Nihon Soshikigaku Kiroku·T Fujita
Mar 1, 1984·Biomaterials·V LenaertsP Speiser
Dec 23, 1981·Biochimica Et Biophysica Acta·R M Abra, C A Hunt
May 22, 1996·Biochimica Et Biophysica Acta·C D OjaP R Cullis
Apr 29, 1998·Antimicrobial Agents and Chemotherapy·K V Clemons, D A Stevens
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BerryF J Martin
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A GabizonY Barenholz
May 17, 2000·Journal of Biomedical Materials Research·D A EavaroneR V Bellamkonda
Jul 11, 2000·Pharmaceutical Research·S DokkaY Rojanasakul
Jul 14, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H TakeuchiY Kawashima
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·J W ParkC C Benz
Dec 18, 2001·Advanced Drug Delivery Reviews·P Meers
May 9, 2002·Biochimica Et Biophysica Acta·Nancy Dos SantosMarcel B Bally
Jul 12, 2002·Cancer Chemotherapy and Pharmacology·Daniel J BooserGabriel N Hortobagyi
Dec 11, 2002·Expert Opinion on Pharmacotherapy·Gerald BatistLauri Welles
May 13, 2003·Clinical Pharmacokinetics·Alberto GabizonYechezkel Barenholz
Jun 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gregory J R Charrois, Theresa M Allen
Jun 20, 2003·Progress in Lipid Research·P Sapra, T M Allen
Sep 13, 2003·British Journal of Clinical Pharmacology·Georg HempelJoachim Boos
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lars H LindnerMarc Dellian
Mar 27, 2004·Drugs of Today·Prabhakar R Veerareddy, Venkateswarlu Vobalaboina
Jul 23, 2004·Expert Opinion on Therapeutic Targets·Charles O NobleDaryl C Drummond
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles M RudinMark J Ratain
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin

❮ Previous
Next ❯

Citations

Aug 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Scott EliasofMark E Davis
Mar 28, 2013·Journal of Drug Delivery·Federico Perche, Vladimir P Torchilin
Dec 24, 2013·International Journal of Pharmaceutics·Martha L Vázquez-GonzálezJordi Hernández-Borrell
Jun 26, 2013·Expert Opinion on Drug Delivery·Erik Oude BlenkeRaymond M Schiffelers
Nov 17, 2015·Molecular Pharmaceutics·Francois T H YuFlordeliza S Villanueva
Jul 31, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Ryan F SchellWilliam C Zamboni
Jan 8, 2016·Toxicology and Applied Pharmacology·Marina A DobrovolskaiaAnna A Shvedova
Sep 9, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marina A Dobrovolskaia
Nov 17, 2015·Nature Reviews. Drug Discovery·Jonathan E Zuckerman, Mark E Davis
Mar 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yi ZhaoAlexander V Kabanov
May 18, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Yu-Wen WuThierry Burnouf
Jun 6, 2016·Advanced Drug Delivery Reviews·Shawn StapletonMichael Milosevic
Jun 12, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Gina SongWilliam C Zamboni
Oct 18, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Andrew T LucasWilliam C Zamboni
Oct 27, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephan T SternDavid M Stevens
Nov 30, 2016·Pharmaceutical Research·Michael A CollierKristy M Ainslie
Mar 14, 2017·Nano Letters·Jillian L PerryJoseph M DeSimone
Feb 1, 2018·Oncotarget·Jie YangJiaying Zhou
Sep 8, 2020·Journal of Liposome Research·Yiying GuYunjun Liu
Nov 24, 2020·Advanced Healthcare Materials·Morgan E LorkowskiEfstathios Karathanasis
Apr 27, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Whitney P CaronWilliam C Zamboni
Sep 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gina SongWilliam C Zamboni
Jan 27, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dandan LuoJonathan F Lovell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Drug Discovery
Vladimir P Torchilin
Expert Opinion on Biological Therapy
N MaurerP R Cullis
Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
Istvan Szelenyi
Trends in Biotechnology
Mariana BeijaJean-Daniel Marty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
William C Zamboni
© 2022 Meta ULC. All rights reserved